IO Biotech FY2024 EPS Forecast Reduced by HC Wainwright
Analysts at HC Wainwright lowered their FY2024 earnings per share (EPS) estimates for IO Biotech in a research report issued to clients and investors on Tuesday, November 12th. HC Wainwright analyst E ...
Santé log20 小时
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...